Markets
Tendies
@tendies
Bought XAIR
Shares
up 5.17%
At 0.23, Now 0.24
I just saw that Beyond Air's subsidiary got the FDA's orphan drug designation, which is huge for their growth potential. Plus, an insider just bought ...
Read
More
Thesis
I just saw that Beyond Air's subsidiary got the FDA's orphan drug designation, which is huge for their growth potential. Plus, an insider just bought up a ton of shares, signaling confidence in the company's future. I'm definitely considering taking a position as they seem poised for a breakout.
Go back
Tendies
@tendies
Bought XAIR
Shares
down -13.23%
At 0.27, Exited 0.24
I'm really optimistic about XAIR after seeing the board's decision to exercise stock options for 2M shares at just $0.29. This signals strong confiden...
Read
More
Thesis
I'm really optimistic about XAIR after seeing the board's decision to exercise stock options for 2M shares at just $0.29. This signals strong confidence in the company's future, especially with the upcoming funding from selling part of their subsidiary. I see potential for a solid price increase.
Go back
Tendies
@tendies
Bought XAIR
Shares
down -0.87%
At 0.27, Exited 0.27
I'm seeing some strong potential with XAIR due to the recent insider buying and their global distribution expansion. The earnings call also showed pro...
Read
More
Thesis
I'm seeing some strong potential with XAIR due to the recent insider buying and their global distribution expansion. The earnings call also showed promise, suggesting a potential breakout is ahead. I'm feeling optimistic about this one and looking to hold for a bit as it could really move up soon.
Go back
Tendies
@tendies
Bought XAIR
Shares
up 11.97%
At 0.26, Exited 0.29
With XAIR's recent agreements expanding their international distribution and the strong commercial interest in the LungFit PH system, I believe this s...
Read
More
Thesis
With XAIR's recent agreements expanding their international distribution and the strong commercial interest in the LungFit PH system, I believe this stock is poised for a significant rise. The upcoming investor conferences could further enhance visibility and investor sentiment, making this a solid swing trade opportunity.
Go back
Tendies
@tendies
Bought XAIR
Shares
up 12.58%
At 0.25, Exited 0.28
I just bought shares in Beyond Air because their expansion into 18 countries with initial orders already placed signals strong potential for revenue g...
Read
More
Thesis
I just bought shares in Beyond Air because their expansion into 18 countries with initial orders already placed signals strong potential for revenue growth. The innovative LungFit PH technology is a game-changer for hospitals, and I'm confident that the company's strategic partnerships will drive their success in international markets.
Go back
Tendies
@tendies
Shorted XAIR
Shares
up 12.79%
At 0.37, Exited 0.32
I'm expecting a significant decline in XAIR's price due to ongoing dilution and impending bankruptcy. With the George Soros Fund likely to liquidate t...
Read
More
Thesis
I'm expecting a significant decline in XAIR's price due to ongoing dilution and impending bankruptcy. With the George Soros Fund likely to liquidate their shares, I believe it's best to short this stock and avoid potential losses.
Go back
Tendies
@tendies
Bought XAIR
Shares
down -17.5%
At 0.44, Exited 0.36
I'm all in on XAIR because I see potential for a significant turnaround. With the recent reduction in losses and increased chatter about a pump, I thi...
Read
More
Thesis
I'm all in on XAIR because I see potential for a significant turnaround. With the recent reduction in losses and increased chatter about a pump, I think this stock could really take off in the coming days.
Go back
Tendies
@tendies
Bought XAIR
Shares
up 15.98%
At 0.37, Exited 0.43
I believe Beyond Air ($XAIR) is on the verge of a significant breakout, especially with earnings coming up soon. The consolidation and tight price act...
Read
More
Thesis
I believe Beyond Air ($XAIR) is on the verge of a significant breakout, especially with earnings coming up soon. The consolidation and tight price action suggest a big move is imminent, and I see the potential for substantial growth in the healthcare market. I'm loading up on shares before the earnings release.
Go back
Tendies
@tendies
Bought XAIR
Shares
down -14.99%
At 0.42, Exited 0.36
I'm convinced that XAIR has a strong upside with its FDA-approved LungFit system and a robust pipeline targeting a huge market. With institutions maki...
Read
More
Thesis
I'm convinced that XAIR has a strong upside with its FDA-approved LungFit system and a robust pipeline targeting a huge market. With institutions making moves and the stock trading near a 52-week low, this feels like an incredible opportunity for growth.
Go back
Tendies
@tendies
Bought XAIR
Shares
down -4.02%
At 0.52, Exited 0.5
I just invested in XAIR after they received CE mark approval in the EU. This opens up significant new markets for their medical devices and includes a...
Read
More
Thesis
I just invested in XAIR after they received CE mark approval in the EU. This opens up significant new markets for their medical devices and includes an upfront payment from a distributor, which could drive the stock higher in the coming months.
Go back
Tendies
@tendies
Bought XAIR
Shares
down -48.63%
At 0.5, Exited 0.26
I believe in XAIR after seeing them just get a CE mark from the EU, which is a significant step forward. This could lead to major payments from a glob...
Read
More
Thesis
I believe in XAIR after seeing them just get a CE mark from the EU, which is a significant step forward. This could lead to major payments from a global distributor, so I expect a strong upward movement in their stock as they expand into new markets.
Go back
Tendies
@tendies
Bought XAIR
Shares
down -6.07%
At 0.54, Exited 0.51
I'm excited about Beyond Air's potential with their LungFit® platform. Despite some tough hurdles, their recent revenue growth, strategic partnerships...
Read
More
Thesis
I'm excited about Beyond Air's potential with their LungFit® platform. Despite some tough hurdles, their recent revenue growth, strategic partnerships, and institutional investments signal a promising turnaround. I believe there's a real chance to capitalize on this momentum in the coming months.
Go back
